Clinical Trial Update: Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intracoronary infusion of autologous bone marrow cells for idiopathic dilated cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Autologous bone marrow cells

Snippet

Sponsor: Fundación Pública Andaluza Progreso y Salud | Conditions: Dilated Cardiomyopathy | Phase 2 | Status: COMPLETED